Pathway,Score
Signaling by VEGF,0.039432098062764355
Negative regulation of the PI3K/AKT network,0.010331391384176172
PI3K/AKT Signaling in Cancer,0.04795532276343427
G beta:gamma signalling through PI3Kgamma,0.10216940973091865
G-protein beta:gamma signalling,-0.005261101528126405
VEGFA-VEGFR2 Pathway,-0.001976604340651646
VEGFR2 mediated vascular permeability,0.013385238795142102
Constitutive Signaling by AKT1 E17K in Cancer,0.05856801848736679
Respiratory Syncytial Virus Infection Pathway,0.064873842464326
RSV-host interactions,0.0674466899559654
RHO GTPases Activate WASPs and WAVEs,-0.004503721581058167
RAC2 GTPase cycle,0.02211511082574251
RAC3 GTPase cycle,-0.07222590787118624
Parasite infection,0.07677574843378081
Leishmania phagocytosis,0.01706869013644802
FCGR3A-mediated phagocytosis,0.04124026151229846
Signaling by NOTCH1,0.009921576432740189
NOTCH1 Intracellular Domain Regulates Transcription,-0.009465360628308416
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.013790897377450007
Signaling by NOTCH1 in Cancer,0.01597730233515768
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.03721226848291616
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.07289157986890055
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.005846566334153068
Regulation of PTEN gene transcription,0.03073154527193385
Budding and maturation of HIV virion,0.061223972757440306
Uptake and actions of bacterial toxins,0.011282019845059263
Bacterial Infection Pathways,-0.017313585216726782
NRAGE signals death through JNK,0.005647296821107733
p75 NTR receptor-mediated signalling,-0.012088430881089313
"Cell death signalling via NRAGE, NRIF and NADE",0.04510751872445778
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,-0.002405789514108367
Neurodegenerative Diseases,0.041561060422339514
Diseases of programmed cell death,0.07808264782394544
Defective Intrinsic Pathway for Apoptosis,0.00023590667696927244
Signaling by SCF-KIT,0.0017690625563325595
Regulation of KIT signaling,0.010015423147160432
Degradation of beta-catenin by the destruction complex,0.006634574695675523
Beta-catenin phosphorylation cascade,0.009610365050686881
Disassembly of the destruction complex and recruitment of AXIN to the membrane,-0.00885144958828345
G alpha (12/13) signalling events,0.03174494008638325
Pre-NOTCH Transcription and Translation,-0.04493619300470348
Pre-NOTCH Expression and Processing,-0.02208864409928363
Signaling by NOTCH2,-0.053075898806877256
NOTCH2 intracellular domain regulates transcription,-0.032325691687076816
Signaling by NOTCH3,0.015522273780841965
NOTCH3 Intracellular Domain Regulates Transcription,-0.02471269527595699
Signaling by NOTCH4,-0.009344624257822662
NOTCH4 Intracellular Domain Regulates Transcription,-0.0004741168899054717
Signaling by MET,0.020023568986742898
RAS processing,0.029333107564830877
Potential therapeutics for SARS,-0.13203881720143829
Host Interactions of HIV factors,-0.07439638400397842
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.023630938961179616
The role of Nef in HIV-1 replication and disease pathogenesis,0.008026841678172334
NR1H2 and NR1H3-mediated signaling,0.021325979810049325
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.058917474111736715
Diseases of glycosylation,0.06131436677139652
Diseases associated with O-glycosylation of proteins,0.00742565749870131
Defective GALNT3 causes HFTC,-0.01601393938878193
Defective GALNT12 causes CRCS1,0.027391033304468456
Diseases of metabolism,0.03448794619383837
Diseases of DNA repair,0.033858417277295584
Diseases of DNA Double-Strand Break Repair,-0.008946616735181184
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.008025082726958427
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.005712897400805497
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.010205864789261167
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,0.002326018324957236
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.0005031377805026707
Impaired BRCA2 binding to RAD51,0.005352130353095988
Impaired BRCA2 binding to PALB2,0.04066964871314257
Effects of PIP2 hydrolysis,-0.11860087954894959
Integrin signaling,-0.0023277253893336865
Retrograde neurotrophin signalling,-0.0073926188466458135
Signaling by NTRK1 (TRKA),-0.13460462681524005
TNFR1-induced proapoptotic signaling,-0.03758339119752206
Regulation of TNFR1 signaling,-0.04245349606699853
TNFR1-induced NF-kappa-B signaling pathway,0.09497713986699173
TNF signaling,0.016726180823739344
RHOA GTPase cycle,0.052224805201747396
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.0035671275789138025
HCMV Infection,-0.000784468535802811
HCMV Early Events,7.58200246826466e-05
Regulation of RAS by GAPs,-0.1706562303233781
RHOF GTPase cycle,-0.007193071319775464
P2Y receptors,-0.0015234880996136608
Nucleotide-like (purinergic) receptors,0.025022057537978416
Signaling by PTK6,-0.06784964494857806
Signaling by Non-Receptor Tyrosine Kinases,0.025399967495792944
Signaling by Retinoic Acid,-0.013961896585300797
RA biosynthesis pathway,-0.04083064357694192
Signaling by ERBB2,-0.0021746992986003853
Downregulation of ERBB2 signaling,0.0079867750555869
Activated NOTCH1 Transmits Signal to the Nucleus,0.0061002709776727775
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.03665982673357484
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.03029207426047045
Opioid Signalling,-0.05557244069233097
DARPP-32 events,0.05294608943665758
Nuclear Events (kinase and transcription factor activation),-0.006641076810886908
Signaling by NTRK2 (TRKB),-0.0056202881488168766
NGF-stimulated transcription,-0.004704915272059861
Class B/2 (Secretin family receptors),0.046925952851150254
G alpha (s) signalling events,-0.06604433890607853
RHOB GTPase cycle,-0.005770057294581318
RHOC GTPase cycle,-0.0026167179522377233
Vpu mediated degradation of CD4,0.006869655866106798
Vif-mediated degradation of APOBEC3G,-0.0649000682210276
PCP/CE pathway,-0.08457941757798143
Asymmetric localization of PCP proteins,0.07867984406651594
Degradation of AXIN,0.030993863070222127
Degradation of DVL,-0.020199003952123276
Hedgehog ligand biogenesis,-0.01059926714489774
Hh mutants are degraded by ERAD,0.0055077760507770855
Hh mutants abrogate ligand secretion,0.015082674193995914
Degradation of GLI1 by the proteasome,-0.005738397368634814
Degradation of GLI2 by the proteasome,-0.07247511061244001
GLI3 is processed to GLI3R by the proteasome,-0.0068520392302331475
Hedgehog 'off' state,-0.0001398586991803017
ABC transporter disorders,-0.021138049789317256
Disorders of transmembrane transporters,0.007976824489783998
Hedgehog 'on' state,0.061359265000071044
Defective CFTR causes cystic fibrosis,0.06650124524474443
MAPK6/MAPK4 signaling,0.015021047000305307
Regulation of PTEN stability and activity,-0.0019194592502771773
Negative regulation of NOTCH4 signaling,0.0021531321946157912
Formation of HIV elongation complex in the absence of HIV Tat,-0.019414853728374187
Formation of the HIV-1 Early Elongation Complex,-0.001668067216987795
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.019514503315813322
HIV Transcription Initiation,-0.010763929220813715
RNA Polymerase II HIV Promoter Escape,-0.01960172191024546
HIV Transcription Elongation,-0.04583793914237702
Transcription of the HIV genome,0.0060516688597139386
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.006770004158554596
Tat-mediated elongation of the HIV-1 transcript,-0.012737407132502007
RHOBTB3 ATPase cycle,0.006434976696146606
Signaling by TGF-beta Receptor Complex,0.03613665756203048
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.054932910814331215
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.06965863104881252
Pausing and recovery of Tat-mediated HIV elongation,0.022407460722182703
Tat-mediated HIV elongation arrest and recovery,-0.013877483921752124
HIV elongation arrest and recovery,0.00995804515549901
Pausing and recovery of HIV elongation,-0.01852487782314443
Estrogen-dependent gene expression,0.009362866508291422
RHOBTB2 GTPase cycle,0.037019419560415545
RHOBTB1 GTPase cycle,0.03677231450018331
RHOBTB GTPase Cycle,-0.04310351670950942
Signaling by EGFR,0.007728316544169315
EGFR downregulation,-0.004837697991796841
Signaling by FGFR,0.06984231685532288
Negative regulation of FGFR1 signaling,0.018535785956938083
Negative regulation of FGFR2 signaling,0.016438887299318937
Negative regulation of FGFR3 signaling,-0.010157548984392787
Negative regulation of FGFR4 signaling,0.04195212687771217
Signaling by FGFR1,0.030215711182637134
Signaling by FGFR2,0.008715932590598517
Signaling by FGFR3,-0.02709254239529396
Signaling by FGFR4,0.020638426679867265
Negative regulation of MET activity,-0.00942726531645141
InlB-mediated entry of Listeria monocytogenes into host cell,0.03277974009168109
Listeria monocytogenes entry into host cells,0.010730372297156739
RHOU GTPase cycle,0.007714120710303807
MAP2K and MAPK activation,0.0005412719229067434
Signaling by moderate kinase activity BRAF mutants,0.023100168604943398
Signaling by high-kinase activity BRAF mutants,0.02666942943041481
Signaling by RAS mutants,0.002579371671941649
Signaling by BRAF and RAF1 fusions,-0.04220011334776883
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.009331450718420212
Oncogenic MAPK signaling,-0.011704031968368767
Signaling downstream of RAS mutants,0.010060548627753144
Signaling by RAF1 mutants,0.03778929790556415
AKT phosphorylates targets in the cytosol,-0.007756956876920757
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.0015467403470835214
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.039962360670938196
Diseases of mitotic cell cycle,-0.001955437047526641
FLT3 signaling in disease,-0.004442332810020201
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.02378880138763094
Signaling by ALK in cancer,-0.13698914969380163
Signaling by FLT3 ITD and TKD mutants,-0.01230831069343286
Signaling by ALK fusions and activated point mutants,-0.028804522269840562
RHO GTPases activate CIT,0.03333276035657725
Extra-nuclear estrogen signaling,0.04331415244639762
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.00978792241857755
Signaling by Activin,0.0018892900864347206
Downregulation of TGF-beta receptor signaling,-0.016678919599391964
TGF-beta receptor signaling activates SMADs,0.036274177389920725
G alpha (z) signalling events,-0.0165217316542297
Activation of RAC1,-0.0005935100291732134
RHOQ GTPase cycle,-0.033569791943016514
RHOH GTPase cycle,-0.03908526616652765
RHOG GTPase cycle,-0.041120947845996125
RHOJ GTPase cycle,0.07825412139194476
RHOV GTPase cycle,0.00793588574472941
Signaling by Insulin receptor,0.03630989944465112
Insulin receptor recycling,0.024384203575715892
MET activates PTK2 signaling,0.008165860534152787
MET promotes cell motility,-0.03933258107334565
MTOR signalling,-0.0006065218014243731
mTORC1-mediated signalling,0.0008349812888828193
Energy dependent regulation of mTOR by LKB1-AMPK,0.01197330438935164
Diseases of Immune System,0.004328689553442442
Diseases associated with the TLR signaling cascade,-0.021763868142212813
RHO GTPases activate IQGAPs,-0.014533743715672998
RHO GTPases Activate Formins,0.046049566072736574
RHO GTPases activate PKNs,-0.024307592174193628
RHO GTPases Activate ROCKs,0.00015134132880135814
RHO GTPases activate PAKs,-0.05719616491209613
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.029540728826587256
Pre-NOTCH Processing in Golgi,0.004138823454507032
Signaling by ERBB4,-0.005473302037350527
Nuclear signaling by ERBB4,0.01871984434031931
Signaling by Hippo,0.05720667858130335
RHOD GTPase cycle,-0.007293340441082861
SARS-CoV-1-host interactions,-0.29768996166744205
SARS-CoV-1 activates/modulates innate immune responses,-0.025136727616170057
RND3 GTPase cycle,0.0271179885512381
Nuclear events stimulated by ALK signaling in cancer,-0.0004538536147372433
HCMV Late Events,-0.05531917234078413
Formation of the beta-catenin:TCF transactivating complex,0.010485480182740464
Peptide ligand-binding receptors,-0.030003941646147926
Chemokine receptors bind chemokines,0.014845903704467067
Translation of Structural Proteins,0.002564825793422553
Maturation of spike protein,0.00880635444849442
Late SARS-CoV-2 Infection Events,-0.030594945235694806
Purinergic signaling in leishmaniasis infection,-0.02324475540302182
Cell recruitment (pro-inflammatory response),0.019429778561855283
CaMK IV-mediated phosphorylation of CREB,-0.0006273787999331749
Calmodulin induced events,-0.016345275712236342
Ca-dependent events,0.017717799681354448
CaM pathway,-0.0022619288191850296
G-protein mediated events,0.006189823790323882
PLC beta mediated events,-0.055497051765013676
DAG and IP3 signaling,0.009168726162736833
G-protein activation,0.005443028029983902
Ca2+ pathway,-0.06642268149263705
G beta:gamma signalling through PLC beta,-0.002618203081753835
Glucagon-type ligand receptors,0.027177396651375
G beta:gamma signalling through BTK,-0.012750551079564883
G beta:gamma signalling through CDC42,-0.02464188874351109
GPER1 signaling,0.015093842344519999
ADORA2B mediated anti-inflammatory cytokines production,-0.009000879668196234
Anti-inflammatory response favouring Leishmania parasite infection,0.004378040317951252
Leishmania parasite growth and survival,-0.020741760964524476
PKA-mediated phosphorylation of CREB,-0.024844540332865005
PKA activation,0.027057580781688885
Adenylate cyclase activating pathway,0.0013813697887230263
Adenylate cyclase inhibitory pathway,-0.009652618508666827
FCGR3A-mediated IL10 synthesis,-0.007439284831097454
Signaling by ERBB2 in Cancer,0.00368928582112126
Constitutive Signaling by Aberrant PI3K in Cancer,0.0015041696328106696
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.06302764094270152
Signaling by ERBB2 KD Mutants,-0.006872608352378736
Signaling by ERBB2 TMD/JMD mutants,0.0009910085268415335
RND2 GTPase cycle,0.014740729964885468
Signaling by TGFBR3,0.061552502631739316
Rev-mediated nuclear export of HIV RNA,-0.006425016118882219
Transport of Ribonucleoproteins into the Host Nucleus,0.008669114535123246
Export of Viral Ribonucleoproteins from Nucleus,-0.018633655324609047
NS1 Mediated Effects on Host Pathways,-0.015964326409900628
Viral Messenger RNA Synthesis,0.0199975606567845
NEP/NS2 Interacts with the Cellular Export Machinery,0.0111994798405925
Interactions of Vpr with host cellular proteins,0.02771548047735186
Interactions of Rev with host cellular proteins,-0.010344048436367773
Nuclear import of Rev protein,-0.029445584947141844
Vpr-mediated nuclear import of PICs,0.008337484258980026
SLC transporter disorders,-0.02225338576268605
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.01309694852271388
VEGFR2 mediated cell proliferation,-0.0017357345702328267
Eicosanoid ligand-binding receptors,-0.022466401634587848
RHO GTPases Activate NADPH Oxidases,0.0034981188076991117
Downstream signaling of activated FGFR1,-0.007914973202003924
FRS-mediated FGFR1 signaling,-0.005915619285703141
Downstream signaling of activated FGFR2,0.009173397023391603
FRS-mediated FGFR2 signaling,0.002953232147619418
FRS-mediated FGFR3 signaling,0.0005191488255556312
Downstream signaling of activated FGFR3,-0.08729506771605021
FRS-mediated FGFR4 signaling,0.006078678464946821
Downstream signaling of activated FGFR4,-0.02558236428330098
RND1 GTPase cycle,-0.028415058667420046
Signaling by FGFR in disease,0.02441562793172927
Prolonged ERK activation events,-2.3322887347282246e-05
Frs2-mediated activation,-0.0056760271485558735
Signalling to ERKs,-0.1538101307234381
Signaling by ALK,-0.010350449237434535
Signaling by FGFR2 in disease,-0.07332113998380047
Signaling by FGFR1 in disease,-0.04621744900041275
Signaling by FGFR3 in disease,0.01103656221908857
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.0016958445930459886
Activation of SMO,0.0005441684651873735
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.005085467456084503
Signaling by EGFR in Cancer,0.01159477475525695
Constitutive Signaling by EGFRvIII,0.000436370520896246
Signaling by EGFRvIII in Cancer,-0.00012242781267501006
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.033206538565094035
Signaling by ERBB2 ECD mutants,0.024784842319995316
Infection with Mycobacterium tuberculosis,0.0010038390247694025
Response of Mtb to phagocytosis,-0.012731349594990391
Signaling by BMP,-0.022465636859052635
Early Phase of HIV Life Cycle,-0.0027067211787432763
SARS-CoV-2 modulates host translation machinery,-0.004284660685075886
RAF-independent MAPK1/3 activation,0.005699470539828739
Negative regulation of MAPK pathway,0.0035932801901160474
Viral mRNA Translation,-0.005358788184782195
Amine ligand-binding receptors,-0.02346272485576737
Neurotoxicity of clostridium toxins,0.014069714978022478
SARS-CoV-2 modulates autophagy,-0.002953347770503036
PI3K Cascade,-0.02587942393616676
IRS-mediated signalling,-0.024162424952753232
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.03862633251910886
IGF1R signaling cascade,-0.06290348904622725
IRS-related events triggered by IGF1R,0.00039546302960066575
Insulin receptor signalling cascade,-0.010774195413410188
WNT5A-dependent internalization of FZD4,0.009498140961656269
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.05922196450447906
Induction of Cell-Cell Fusion,-0.014484983176784507
Signaling by PDGF,0.0015733517945095599
Translation of Replicase and Assembly of the Replication Transcription Complex,0.030485652952971207
Early SARS-CoV-2 Infection Events,0.036315850467241576
Assembly Of The HIV Virion,-0.062230880146405196
Evasion by RSV of host interferon responses,0.012531150106333794
Downstream signal transduction,0.015851203322005045
p130Cas linkage to MAPK signaling for integrins,-0.05053664286745918
Signaling by Erythropoietin,0.024013256849903488
SARS-CoV-1 modulates host translation machinery,0.015853210554813625
Downregulation of SMAD2/3:SMAD4 transcriptional activity,-0.000853125624809965
Maturation of nucleoprotein,0.006023346142544691
Signalling to RAS,0.03286479744230284
FGFR2 ligand binding and activation,-0.00039586846129265166
Signaling by WNT in cancer,-0.04297698833814825
Signaling by AXIN mutants,0.039397794395050444
Signaling by CTNNB1 phospho-site mutants,0.0009703445624601875
Signaling by APC mutants,0.002973080443815603
Signaling by AMER1 mutants,0.012363147413628595
Signaling by GSK3beta mutants,-0.004337143732516288
CTNNB1 S33 mutants aren't phosphorylated,-0.01143125560564986
CTNNB1 S37 mutants aren't phosphorylated,0.042855338564084904
CTNNB1 S45 mutants aren't phosphorylated,0.0035212125184016048
CTNNB1 T41 mutants aren't phosphorylated,0.004097831185769307
APC truncation mutants have impaired AXIN binding,-0.020848475216650595
AXIN missense mutants destabilize the destruction complex,-0.010778398194086254
Truncations of AMER1 destabilize the destruction complex,-0.006576799619443645
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.020562610805638367
Maturation of hRSV A proteins,-0.003912247365815562
RHO GTPases activate KTN1,-0.001785654703178145
Deactivation of the beta-catenin transactivating complex,0.005992717239730102
Repression of WNT target genes,0.01371721160121472
FGFR4 ligand binding and activation,-0.00773888030555437
Phospholipase C-mediated cascade; FGFR4,0.037459931977311206
SHC-mediated cascade:FGFR4,0.016979275357953665
PI-3K cascade:FGFR4,0.03240165951580351
STAT3 nuclear events downstream of ALK signaling,0.006854316382472289
Defective pyroptosis,-0.055008259137224784
ERK/MAPK targets,-0.013562298341582206
ERKs are inactivated,0.02492542140074807
TGFBR3 expression,-0.006446222230314768
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.02404926076214075
Class C/3 (Metabotropic glutamate/pheromone receptors),0.14185151695113427
FGFR1 mutant receptor activation,-0.007588726252869948
FGFR2 mutant receptor activation,0.005719407149175709
Activated point mutants of FGFR2,0.058898102885640506
Phospholipase C-mediated cascade; FGFR2,-0.00995041541715317
PI-3K cascade:FGFR1,-0.011659180287700684
PI-3K cascade:FGFR2,-0.00713143200562433
SHC-mediated cascade:FGFR2,-0.0006322707619620117
Signaling by FGFR2 IIIa TM,-0.006759366153944462
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.0071816894697673125
Abortive elongation of HIV-1 transcript in the absence of Tat,0.007868377574027962
FGFR2 alternative splicing,0.004371165739093554
Regulation of PTEN mRNA translation,0.03254307446263328
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.01847275907941274
NRIF signals cell death from the nucleus,-0.00011182039083707724
Signaling by KIT in disease,-0.015728875497126454
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.015128935575132516
Loss of function of MECP2 in Rett syndrome,-0.014517396877684153
Pervasive developmental disorders,-0.004237433886662427
Disorders of Developmental Biology,0.024495869997567872
Disorders of Nervous System Development,0.017540859633599755
Defects in vitamin and cofactor metabolism,-0.007137907515310685
Regulation of FZD by ubiquitination,-0.0019977288645987097
Serotonin receptors,0.010560421179514874
p75NTR signals via NF-kB,0.0564025782293858
Signaling by NTRK3 (TRKC),-0.008497758702331961
RAF activation,-0.007391251282513689
p75NTR regulates axonogenesis,0.004082631038088871
WNT ligand biogenesis and trafficking,-0.015305451978543654
